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Background: Non-motor symptoms are increasingly recognized in Parkinson’s Disease (PD) and include physical as 
well as psychological symptoms. A psychological condition that has been well studied in PD is psychosis. 
Cardiovascular autonomic dysfunction in PD can include a reversed or lack of blood pressure (BP) circadian 
rhythm, referred to as nocturnal non-dipping. The aim of this study was to determine the relationship between 24 hr 
ambulatory blood pressure measurements (ABPM), e.g., absence or presence of nocturnal dipping, and psychosis 
scores in PD. 
Methods: 21 patients with Parkinson’s disease underwent 24 hr ABPM using an autonomic protocol. A decrease in 
nocturnal mean arterial blood pressure (MAP) of less than 10% was defined as non-dipping. Patients were 
interviewed (including the Brief Psychiatric Rating Scale; BPRS) for the assessment of psychosis.  
Results: 11 patients were dippers and 10 were non-dippers. BPRS scores were higher in non-dippers who on average 
met the criteria for psychosis (mean non-dipper BPRS: 34.3± 7,3 vs mean dipper BPRS: 27.5 ±5,3; cut off for 
“mildly ill” 31). There was a correlation between BPRS scores and non-dipping, indicating that those patients who 
had a blunted nocturnal fall in BP were more prone to psychotic symptoms.(Pearson’s Correlation = .554, p =.009). 
Conclusion: These results suggest that a blunted BP rhythm in Parkinson’s disease patients may possibly be 
associated with psychosis symptoms compared to patients whose BP decreases physiologically at night. This 
association warrants further investigation. 
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Introduction 
The cardinal features of Parkinson’s disease include rigidity, bradykinesia, resting tremor and postural instability.[1] 
Non-motor symptoms are also being increasingly recognized in PD, such as neuropsychiatric symptoms and 
autonomic dysfunction amongst others, and are often the main cause of disability having a significant impact on 
quality of life[2] and are quite frequently the reason patients are moved to nursing homes[3]. Cardiovascular 
symptoms are typical features of an impaired autonomic nervous system. These include orthostatic hypotension[4], 
or a loss of the circadian rhythm of blood pressure, characterized by ‘non-dipping’[5]; defined as a blunted, or 
absent decrease in blood pressure while sleeping at night.[6]  
The human body is tuned to an (approximately) 24h rhythm, which is inter alia aligned by light and dark cycles. 
Circadian rhythms help with the entrainment of various key daily activities and functions, such as, sleep patterns, 
alertness, physical strength, blood pressure and even mood.[7] Twenty-four hour patterns and any associated 
circadian dysrhythmia, particularly an impaired blood pressure rhythm, have recently become of great interest to 
clinicians[8]. A blunted or even a reversed blood pressure circadian rhythm (e.g. non-dipping) is associated with end 
organ damage[9] and higher cardiovascular morbidity[10]. Furthermore, it has been suggested that non-dipping is 
also associated with other non-cardiovascular symptoms such as psychosocial factors.[11]  
Non-dipping is common in PD, and ranges in prevalence from 40%[12] to 92%[13]. The reasons for a 
blunted/reversed circadian blood pressure rhythm in PD can include several factors, including pathological entities, 
such as disorders of nocturnal movement, obstructive sleep apnea (OSAS), supine hypertension and reduced quality 
of sleep.[14] Numerous other factors can influence blood pressure profiles at night, such as getting up at night 
secondary to urinary urgency or nocturia (both common in PD).  
Psychiatric illnesses, such as psychosis (an abnormal condition of the mind, which involves a loss of contact with 
reality[15]), have also been linked with abnormal circadian blood pressure regulation.[16] Patients with psychosis 
are at higher risk of developing cardio-metabolic risk factors such as hypertension[17]. Up to 40 %[18] to 60%[19] 
of PD patients suffer from psychosis and 50% of PD patients will suffer from hallucinations (spontaneous aberrant 
perceptions without a physical stimulus[20]) in the course of the disease.[18] The link between abnormal circadian 
blood pressure regulation and psychosis in PD has not been specifically examined however. Such investigations are 
difficult, due to the number of factors that may contribute to psychosis in PD. For example, one of the most 
significant side effects of levodopa is psychosis[21] but only 16% of patients with dopamine agonist or levodopa 
medications develop drug-induced psychosis.[18] Other causes of psychosis could be low quality of sleep[22], 
which is however also likely to cause non-dipping.[14] Up to 90% of PD patients suffer from sleep disruption [23, 
24] which may be caused by the hallmark PD pathophysiology of dopamine depletion which plays a crucial role in 
sleep regulation and circadian homeostasis[23].  
The aim of this study was to therefore determine the relationship between 24 hr ambulatory blood pressure 
measurements (ABPM), e.g., absence or presence of nocturnal dipping, and psychosis parameters in Parkinson’s 
disease, while also considering factors that could influence psychosis scores and non-dipping, such as quality of 
sleep, orthostatic hypotension, levodopa medication and severity/stage of Parkinson’s disease. 
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Methods 
Participants 
A total of 21 patients who met the diagnostic PD criteria of the Queen Square Brain Bank[25] were included in this 
study, which was approved by the ethics committee of the University of Witten/Herdecke and the London, Camden 
& Islington NRES committee. Patients who had symptoms suggestive of atypical PD or any other diagnosis than 
idiopathic PD were excluded. Further exclusion criteria were diabetes and hypertension (or use of antihypertensive 
medication or other medication that could interfere with cardiovascular autonomic function screening, e.g., head up 
tilting, and 24 hr ABPM results). None of the patients were on anti-psychotic medication; only one patient was on 
anti-depressants (mirtazapine 15 mg.) All participants gave verbal and written informed consent prior to the start of 
any testing. All procedures were in line with the Declaration of Helsinki.  
 
Protocol and Instrumentation 
Patients reported to the Unit in the morning in the “off” stage, having been asked to skip the morning dose of their 
anti-PD medication. Patients were first assessed with a range of PD instruments, namely the Unified Parkinson’s 
Disease Rating scale (UPDRS) [26] including the Hoehn and Yahr Scale[27], Schwab and England activities of 
daily living scale and the Parkinson’s Disease Questionnaire (PDQ)[28]. These instruments were complemented 
with the mini mental state examination (MMSE). Additionally, two instruments to assess psychosis in PD 
patients[29] were administered: the brief psychiatric rating scale (BPRS) which usually assesses psychopathology in 
patients with schizophrenia[30], and the positive and negative syndrome scale (PANSS) which usually measures 
symptoms severity in patients with schizophrenia[31], both instruments are however recommended for use with PD 
patients.[29] 
Every patient underwent a head-up tilt test to 60 degrees to ascertain whether or not they met criteria for OH.[6] 
which was defined as a reduction of systolic blood pressure of at least 20 mm Hg or 10 mm Hg in diastolic blood 
pressure within 3 minutes of quiet standing.[32] Afterwards, patients were fitted with an ambulatory blood pressure 
monitor (model 90207, Spacelabs™ Medical, Redmond, Washington) and instructed on how to use it appropriately. 
Automated blood pressure measurements were taken every 30 minutes during day time (07.00-23.00) and every 60 
minutes at night (23.00-07.00).[33] Furthermore, patients were provided with a diary and asked to fill in daily events 
over the 24 hours, including, sleep and wake times, meal times or other food/caffeine intake, time of medications 
and posture (lying down, sitting, standing, walking, exercising) and activity at the time of every reading. Additional 
information, such as symptoms or emotional strain, was also requested to be noted in the diary. Participants were 
also asked to briefly evaluate their quality of sleep and if they got up during the night and if so, for what reason. 
 
Statistical Analyses 
Mean arterial blood pressure was calculated by [(2 x diastolic)+systolic blood pressure] / 3.[34] A normal circadian 
blood pressure profile was defined as a reduction in night time (asleep) mean arterial blood pressure by at least 10% 
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from the daytime (awake) mean arterial BP[6], otherwise known as ‘dipping’. A ‘non-dipping’ circadian BP profile 
was defined as a reduction in night time (asleep) mean arterial blood pressure of less than 10% from the daytime 
(awake) mean arterial BP.[6]A reversed nocturnal BP profile, e.g., an increase at night, was defined as an increase in 
night time (asleep) mean arterial blood pressure by at least 1% from daytime (awake) mean arterial BP.[35]  
 
Indices of circadian blood pressure rhythm (e.g., daytime vs night-time mean values) were compared for the whole 
group using paired t-tests. Patients who met the criteria for dipper vs non-dipper were split into sub-groups and were 
compared using independent t-tests for equality of means (with Levene’s test for equality of variances) or Mann 
Whitney U tests, where appropriate.  Levodopa equivalent dose (LED), a standardized conversion factor for total 
daily anti-parkinsonian drug intake, was calculated following the guidelines of Tomlinson et al (2010).[36] 
The relationships between indices of psychosis and dipping were assessed using Pearson product-moment 
correlation coefficients or Spearman rank order correlations (rho), where appropriate. Preliminary analysis was 
performed to ensure no violations of the assumptions of normality, linearity and homoscedasticity. The evaluation of 
relationship strength was defined by Cohen as small: r=.10 to .29; medium: r=.30 to 49;large: r=.50 to 1.0.[37] 
Indices of psychosis were also correlated with LED, age, disease duration, PDQ, UPDRS, gender, OH and sleep 
quality. The level of significance was set at 0.05. Data are presented as mean ± 1 standard deviation.  
 
 6 
Results 
 
Participant details 
21 patients with PD (15 male, 6 female) were recruited. The average age was 63.9 (±7.6) years and mean disease 
duration (calculated from the time of diagnosis) was 6.6 (±7.0) years. Patients had a mean UPDRS Score of 28 (±13) 
and 38 % were in Hoehn & Yahr stage I, 52% in stage II and 10% in stage III. None of the participants had an 
MMSE score below 28, except for one (MMSE 21) (See Table 1).The mean LED was 423 (±431) mg. The high 
standard deviation was caused by 2 outliers, one of which was due to the patient refusing not to take their anti-
parkinsonian medication on the day of testing. When the outliers were excluded, a mean LED of 359±254 mg was 
evident. The median LED was 200 mg. Only two patients showed orthostatic hypotension (OH), on average, systolic 
blood pressure fell by 9.7±14 mmHg (-7± 9%) during head up tilt. 
 
Ambulatory BP and Psychosis Data 
Ambulatory BP was recorded for a mean duration of 23.8 (±2.4,range 19.0-28.5) hours. The average number of 
measurements obtained in the ~24 h period was 42 (SD 13, range: 26-80). The average amount of sleep at night was 
7.1 hr (±1.8, range: 4-11). 28.5% of patients stated that their quality of sleep was not satisfactory, whilst another 
28.5% (not necessarily the same patients) had to get up at night (e.g. in order to use the bathroom). 
The mean daytime systolic blood pressure was 125 (± 11) mmHg and the mean nighttime systolic blood pressure 
was 117 (±14) mmHg (see Table 2). 47.6% of the patients displayed a non-dipping 24hr BP profile, 3 of which 
displayed a reversed circadian blood pressure rhythm. 11 patients were dippers (52.4%).  
A BPRS score over 31 is considered as ‘mildly ill’, a score over 41 as ‘moderately ill’ and a score over 53 as 
‘markedly ill’[30]. 12 patients (57%) scored over 31, of which, 2 were over 41. When analyzing the PANSS, a score 
of 51 and above was considered ‘mildly ill’[38], which none of the patients reached. The BPRS and PANSS scores 
were highly correlated (Pearson’s R = 0.89; p <.0001).  
 
Sub-group Analyses 
The sub-groups of non-dippers vs dippers did not significantly differ in age (t19 = .137, p = .893), disease duration 
(t19 = -2.039, p= .056), LED (t19 = .757, p= .458) or UPDRS scores (t19 = -2.078, p= .052). Furthermore, no 
difference in gender was found (p=.484; Z=-.701). There was no difference in sleep duration for dippers vs. non-
dippers (p=.137; Z=111.5). 30% of the non-dipper patients reported a bad quality of sleep, compared to 27% of the 
dippers. On HUT, non-dippers exhibited a mean fall in SBP of 13 (± 11) mmHg whereas dippers exhibited a 
decrease of 7 (± 17) mmHg (see Table 1). 
BPRS scores were higher in non-dippers who on average met the criteria for mild psychosis (non-dipper BPRS: 
34.3± 7.3 vs. dipper BPRS: 27.5 ±5.3, p= 0.009; see Table 1). All non-dippers, except one, met (at least) the criteria 
for mild psychosis (PANSS data is depicted in Table 1). There was no difference in BPRS scores (p=.911; Z=-.112) 
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or night time MAP (p=.654; Z=-.448) when comparing those who did and did not sleep well in both dipper and non-
dipper groups. 
 
Correlations 
There was a strong (large) correlation between BPRS and dipping in the whole group (Pearsons r: 0.554, p=.009;see 
Figure 1). The correlation between PANSS scores and dipping was weaker, with a medium correlation (Pearsons r: 
0.394, p=.077). When investigating other factors associated with dipping/non-dipping, only 3 were found to be 
correlated (of medium strength); UPDRS scores (Pearson’s r: .491, p=.024), OH (Pearson’s r: .437, p=.048) and 
disease duration (see Table 3). 
For factors influencing BPRS scores, two statistically significant relationships were evident (see Table 3). PDQ 
(Pearson’s r: .58, p=.01) (Figure 2), and UPDRS scores (Pearson’s r: .48, p=.03) correlated with psychosis. LED 
scores did not correlate with BPRS scores (r:-247, p=.292). 
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Discussion 
The aim of this study was to determine the relationship between 24 hr ambulatory blood pressure measurements 
(ABPM), e.g., absence or presence of nocturnal dipping, and psychosis parameters in Parkinson’s disease, while 
also considering confounding factors that could affect psychosis scores and non-dipping. 
The percentage of non-dipping in this sample was 47.6 %, which falls into the broad prevalence range of 40%[12] to 
92%[13] described in the literature. 57% of the PD patients met the criteria for mild psychosis symptoms, which is 
consistent with previous literature which described a psychosis prevalence of 40%[18] - 60%[19] in PD. PANSS 
scores were correlated strongly with BPRS scores, but none of the patients met the criteria for psychosis according 
to the PANSS (i.e. had scores over 51). This implies that the BPRS is more sensitive in detecting psychosis 
symptoms (at least in PD patients). This could be derived from the fact that the PANSS covers more symptoms of 
psychosis (30 items compared to 18 in the BPRS). It has to be considered though, that two of the 18 BPRS items 
consider motor retardation and mannerism/posturing, which are all symptoms that may be evident in PD patients, 
and not necessarily[39] but possibly linked to psychological symptoms.[40] This might therefore artificially raise 
psychosis scores in PD patients, even though both instruments are recommended by the Movement Disorder Society 
Taskforce.[29]  
The mechanisms of non-dipping in PD are not entirely clear. PD is pathologically characterized by neuronal cell loss 
with deposition of abnormally phosphorylated α-synuclein, found in Lewy bodies.[41, 42] Degeneration with Lewy 
bodies are not only found in the substantia nigra but also in the brainstem nuclei (e.g. pedunculopontine nucleus) 
essential for thalamocortical arousal and therefore REM sleep architecture[43]. Furthermore, Lewy bodies can be 
found in autonomic regulatory areas, such as the parabrachial nucleus, neurons in paravertebral and paravertebral 
autonomic ganglia, hypothalamus.[42] Interestingly, the suprachiasmatic nuclei, which controls circadian rhythms in 
humans lies in the hypothalamus[14], whether this exact part of the hypothalamus is affected by lewy bodies 
remains unclear however. It is therefore possible that the above mentioned aspects of PD pathology in key 
autonomic and circadian areas of the brain might also affect circadian rhythm regulation of blood pressure. 
The absence of circadian BP dipping was associated with OH, disease duration and UPDRS scores. The former is 
also a symptom of an impaired cardiovascular autonomic nervous system, and was thus not unexpected; although 
only 2 patients met the clinical criteria for OH (correlation was conducted with scale data). Previous studies have 
reported an association with OH and supine hypertension[44] which could serve as an explanation for non-dipping 
in PD. The association of non-dipping with UPDRS scores is also not surprising given that cardiovascular symptoms 
are scored as part of the UPDRS and that cardiovascular autonomic dysfunction generally tends to occur in the latter 
stages of PD.[42]  
 
Statistically significant differences in BPRS scores were found when comparing patients showing a non-dipping or 
dipping 24hr BP profile. Furthermore, a positive correlation between psychosis parameters and non-dipping was 
evident, indicating that the smaller magnitude of dipping (i.e. -10% and less) the more likely patients were to have 
higher BPRS scores. Both non-dipper vs. dipper patients, as well as patients with a BPRS above and below the cut-
off of 31, did not differ significantly in age, gender, disease duration or UPDRS scores. 
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Since a correlation does not necessarily imply causation, several factors have to be considered when interpreting the 
correlation between dipping and BPRS data, such as the influence of sleep quality and duration, age, gender, 
levodopa medication, PD severity/stage of the disease. Low quality of sleep may cause non-dipping, due to agitation 
or similar symptoms of sleep deprivation,[14]  which may furthermore cause psychosis.[22] Yet no difference in 
sleep duration for dippers vs. non-dippers was found in this study.  However, a more robust sleep quality instrument 
such as the Pittsburgh sleep quality index (PSQI)[45] and/or objective sleep laboratory measurements might have 
given better insight into sleep quality.  
Levodopa may induce psychosis and could possibly also have an effect on circadian rhythms.[21, 46] We did not 
find a statistically significant correlation between LED and psychosis scores or non-dipping. 
The only significant associations with psychosis (apart from dipping) were for PDQ and UPDRS scores, which 
measure quality of life and disease severity, respectively. This could be interpreted as patients with more severe PD 
symptoms and impaired quality of life tending to have higher psychosis indices. An increased impairment in quality 
of life in those PD patients with a higher psychosis score may also indicate that these patients have a more severe 
subjective perception of illness. The significant correlation between UPDRS and psychosis could be a reflection of 
PD pathology affecting psychosocial function (see below). 
 
The mechanisms of how non-dipping may be associated with psychosis remain elusive. A possible mechanism 
might be related to dopamine which is a common neurotransmitter related to psychosis and circadian rhythms[47] 
and of course to PD pathology [48] and could therefore be a plausible link between the three entities. The role of 
dopamine in psychosis and PD has been well studied[48-50] but is also gaining increasing awareness within the 
field of circadian rhythm disruption.[47] A link between schizophrenia and sleep and circadian rhythm disruptions 
(SCRD) via common neurotransmitters such as dopamine has already been proposed.[43] An explanation for this 
would be that dopamine mediates the relationship between psychosis and Cholecystokinin (CCK), a peptide 
hormone, which possibly plays a role in sleep regulation[47]. CCK furthermore activates orexin, a neurotransmitter 
that has an effect on wakefulness.[47]  
It however remains unclear if a similar association exists within PD. The reasons for a causation between a 
pathological loss of the nocturnal BP fall and psychological symptoms in PD warrants further evaluation.  
In conclusion, 24 hr ABPM revealed that non-dipping BP profiles in PD patients were associated with higher 
psychosis scores than in those patients whose BP drops physiologically at night. No other factors, except disease 
severity scores (PDQ and UPDRS), in this sample of patients were found to influence the psychosis scores.  
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Figure Legends 
 
Figure 1: Scatterplot of Nocturnal MAP dipping and BPRS scores in the whole patient sample. The short-dashed 
horizontal line indicates the horizontal cut-off for psychosis (BPRS score of 31). The dashed vertical line indicates 
the cut off for non-dipping (10%).The  correlation is r - 0.55 (p =.009).  
Figure 2: Scatterplot of PDQ and BPRS scores in the whole patient sample. The dashed vertical line indicates the 
horizontal cut-off for psychosis (BPRS score of 31). The correlation was r= .583 (P=.006).  
Table 1: Overview of Dipper and Non-Dipper sub-group data (mean (SD). 
 
Table 2: Overview of mean (SD) 24 hr ABPM data; BP in mmHg, HR in beats.min-1, P<0.05 vs daytime 
Table 3: Overview of correlations (R (p value)) between BPRS and Dipping and various cardiovascular, medical 
history, medication and disease severity  
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